Chronic Myeloid Leukemia Relapsing as Isolated Extramedullary Disease Presenting as a Cardiac Mass / 대한내과학회지
Korean Journal of Medicine
; : 159-162, 2016.
Article
en Ko
| WPRIM
| ID: wpr-65765
Biblioteca responsable:
WPRO
ABSTRACT
Allogeneic hematopoietic stem cell transplantation is the only option for chemotherapy-refractory chronic myeloid leukemia (CML). Extramedullary relapse after transplantation is rare and usually accompanies marrow relapse. Generally, the prognosis of extramedullary relapse is poor. Here, we report a man with extramedullary relapsed CML after stem cell transplantation that presented as an isolated cardiac mass, which has shown an indolent course for more than 2 years, without evolving to medullary relapse during that period. This case implies that the CML clone might contribute to the development of quiescent extramedullary relapse with a benign course.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Pronóstico
/
Recurrencia
/
Médula Ósea
/
Leucemia Mielógena Crónica BCR-ABL Positiva
/
Células Clonales
/
Trasplante de Células Madre Hematopoyéticas
/
Sarcoma Mieloide
/
Trasplante de Células Madre
/
Neoplasias Cardíacas
Tipo de estudio:
Prognostic_studies
Idioma:
Ko
Revista:
Korean Journal of Medicine
Año:
2016
Tipo del documento:
Article